Eli Lilly's Orforglipron Beats Novo Nordisk's GLP-1 Pill in Tests
Key Points:
- Better injections and better pills. It's official: Eli Lilly appears to be beating Novo Nordisk at the weight loss game.
- On Thursday, Lilly announced that its forthcoming GLP-1 pill, called orforglipr